Status:
UNKNOWN
SmartCardia for the Detection of Myocardial Ischemia in Coronary Artery Disease
Lead Sponsor:
Centre Hospitalier Universitaire Vaudois
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Coronary artery disease and myocardial ischemia are among the leading causes of death and disability in the Westerns countries. Timely and accurate diagnosis of myocardial ischemia at the moment of sy...
Detailed Description
Coronary artery disease and myocardial ischemia are among the leading causes of death and disability in the Westerns countries. Timely and accurate diagnosis of myocardial ischemia at the moment of sy...
Eligibility Criteria
Inclusion
- ≥18 years old patients
- Known coronary artery disease
- Admitted for elective coronary angiography with planned PCI
- Informed consent signed
Exclusion
- urgent procedure with possible ongoing ischemia before procedure (i.e. STEMI and NSTEMI in the acute phase)
- Recent acute coronary syndrome (i.e. STEMI and/or NSTEMI \<48h or with persistent ST elevation)
- Admission for revascularization of a total chronic occlusion
- Known severe valvular disease
- Decompensated heart-failure
- Decompensated pulmonary condition (such as COPD)
- Pregnant and breast-feeding women
- Patients with prior CABG
- Patients with severe renal failure (eGFR \< 30ml/mn)
- Vulnerable patients (minors, participants incapable of judgment or participants under tutelage)
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04810845
Start Date
April 1 2021
End Date
September 1 2021
Last Update
March 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland, 1009